PERSON DIRECTORY
Marty Makary
Marty Makary appears in 1 indexed conversation across All-In. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.
Supercharging a New FDA: Marty Makary on Science, Power & Patients
FDA’s reform agenda targets development speed through centralized reviews, AI completeness checks, one pivotal trial, and fewer animal-testing requirements, potentially saving some companies $100 million to $300 million.Continuous evidence, computational models, and bespoke pathways for cell and gene therapies could increase portfolio throughput while detecting safety signals earlier than conventional review cycles.The competitive test is whether faster U.S. trials can close China’s biotech gap without sacrificing trust, as vaccine, food, pricing, and enforcement reforms remain politically contested.